Male Breast Nodules in Ouagadougou (Burkina Faso): Radiological and Histopathological Aspects

HTML  XML Download Download as PDF (Size: 484KB)  PP. 274-280  
DOI: 10.4236/ojrad.2018.84030    881 Downloads   1,659 Views  Citations

ABSTRACT

Objective: To describe the radiological and histological aspects of breast nodules among men in our practice setting. Methodology: This is a descriptive and retrospective study conducted from January 2014 to October 2017. The study included male patients with breast nodules classified ACR3, 4 or 5 after a mammographic and ultrasound scan. These lesions were explored through an ultrasound-guided breast microbiopsy. The following are the variables collected: age, family history of breast cancer, medical history, ACR classification, nodule size, and anatomopathologic diagnosis. Results: 13 breast nodules were explored among 13 male subjects. Mammography and breast ultrasound enabled to identify one ACR3 lesion, 10 ACR4 lesions and 2 ACR5 lesions. The average age was 56.53 ± 14.63 years and the average size of the nodules 28.91 ± 13.62 mm. As for histology, there were seven malignant tumors and six benign tumors. The average age of patients with malignancy was 61.45 ± 13.62 years. The malignant nodules average size was 29.45 ± 12.54 mm. Malignant tumors exclusively consisted of invasive breast carcinomas while Benign ones consisted of dystrophic and inflammatory lesions. Conclusion: Most often Breast lesions among men had an indeterminate appearance on imaging and were predominantly malignant in histopathology.

Share and Cite:

Ouedraogo, N. , Napon, M. , Tiemtore, B. , Ouattara, B. , Bamouni, A. , Diallo, O. , Sorgho, C. and Cisse, R. (2018) Male Breast Nodules in Ouagadougou (Burkina Faso): Radiological and Histopathological Aspects. Open Journal of Radiology, 8, 274-280. doi: 10.4236/ojrad.2018.84030.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.